|
|
Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 ... - Sacramento Bee |
 |
 |
Sacramento Bee
11, 2011 -- /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced a late-breaking poster presentation at the American Society of Nephrology's (ASN) Kidney Week 2011 Annual Meeting
|
|
|
Worsening Post-Transplant CKD Predicts Higher Graft Failure Risk - Renal and Urology News |
|
|
Renal and Urology News
PHILADELPHIA—Worsening of chronic kidney disease (CKD) stage in the first year following renal transplantation is associated with an increased risk of graft failure, researchers reported at Kidney Week. The findings, from a study of 77206 adult
|
|
IV Iron Use for Anemia Rising, ESA Use Falling - Renal and Urology News |
|
|
Renal and Urology News
An analysis of US Renal Data System data from approximately 250000 HD patients per year for 2002-2008 revealed that the percentage of patients receiving IV iron increased from 63% in the first quarter of 2002 to 76% in the fourth quarter of 2008.
|
|
|
Response to ESAs Predicts ESRD Risk - Renal and Urology News |
|
|
Renal and Urology News
PHILADELPHIA—Patients with chronic kidney disease (CKD) who have a low response to erythropoiesis-stimulating agents (ESAs) are at increased risk of progressing to end-stage renal disease (ESRD), investigators reported at Kidney Week 2011.
|
|
HD-Related Damage Not a Factor in CKD-Related Anemia - Renal and Urology News |
|
|
Renal and Urology News
The study, by Frederiek E. Vos, MD, and colleagues at the University of Otago in Dunedin, New Zealand, included 14 hemodialysis (HD) patients, five peritoneal dialysis (PD) patients, and 14 healthy controls matched for age and gender to the HD patients
|
|
|
|
|
<< Start < Prev 591 592 593 594 595 596 597 598 599 600 Next > End >>
|
|
Page 592 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
